Article info

Download PDFPDF

Adherence and dosing interval of subcutaneous antitumour necrosis factor biologics among patients with inflammatory arthritis: analysis from a Canadian administrative database

Authors

  1. Correspondence to Dr Francois Nantel; fnantel{at}its.jnj.com
View Full Text

Citation

Bhoi P, Bessette L, Bell MJ, et al
Adherence and dosing interval of subcutaneous antitumour necrosis factor biologics among patients with inflammatory arthritis: analysis from a Canadian administrative database

Publication history

  • Received January 19, 2017
  • Revised August 7, 2017
  • Accepted August 8, 2017
  • First published September 18, 2017.
Online issue publication 
September 18, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.